Latest News

24 August 2015

Waterford research on Alzheimer’s disease suggests that measuring macular pigment offers potential as a biomarker of cognitive health

Ongoing European Research Council-funded research at Waterford Institute of Technology’s (WIT) Macular Pigment Research Group (MPRG) is investigating the potential link between cognitive function and levels of a vital eye pigment linked to diet. The study suggests that measuring macular pigment offers potential as a biomarker of cognitive health.

28 July 2015

Coffee Consumption Habits Impact the Risk of Mild Cognitive Impairment: The Italian Longitudinal Study on Aging

A new study estimates the association between change or constant habits in coffee consumption and the incidence of mild cognitive impairment, evaluating 1,445 individuals recruited from 5,632 subjects, aged 65-84 year old, from the Italian Longitudinal Study on Aging, a population-based sample from eight Italian municipalities with a 3.5-year median follow-up.

22 July 2015

New Study Indicates Ankle-Brachial Index Associated with Mild Cognitive Impairment

In a large population-based study of randomly selected participants in Germany, researchers found that mild cognitive impairment occurred significantly more often in individuals diagnosed with a lower ankle brachial index, which is a marker of generalized atherosclerosis and thus cumulative exposure to cardiovascular risk factors during lifetime.

14 July 2015

Affordable, Non-Invasive Test May Detect Who is Most at Risk for Alzheimer's

Photo caption:  Dr. John Hart Jr. (left) and Dr. Hsueh-Sheng Chiang (right), with researchers Drs. Jeremy Strain and Neena Rao, led the study on a new non-invasive test for Alzheimer's disease.

Individuals with amnestic mild cognitive impairment (aMCI) are at twice the risk of others in their age group of progressing to Alzheimer’s disease. Although no conclusive test exists to predict who will develop Alzheimer’s, new research from the Center for BrainHealth at The University of Texas at Dallas is attempting to identify a potential biomarker that could offer a more complete picture of who is most at risk.

26 June 2015

Hartmuth Kolb, PhD, Wins 2015 Alzheimer Award

Hartmuth Kolb

The Journal of Alzheimer’s Disease is proud to announce that Hartmuth Kolb, PhD, Head of Neuroscience Biomarkers, Johnson & Johnson, San Diego, CA, has been chosen as the recipient of the 2015 Alzheimer Award presented by the Journal of Alzheimer’s Disease in recognition of his outstanding work on the importance and imaging of neurofibrillary tangles and Alzheimer’s disease.

24 June 2015

Multiple Pathways Progressing to Alzheimer’s Disease

The amyloid cascade hypothesis of Alzheimer’s disease (AD) posits that sticky aggregations or plaques of amyloid-beta peptides accumulate over time in the brain, triggering a series of events that ultimately result in the full-blown neurodegenerative disorder. However, in a new study published in JAD, researchers at University of California, San Diego School of Medicine and Veterans Affairs San Diego Healthcare System suggest the picture is not so clear-cut, reporting that early indicators or biomarkers of AD development are not fixed in a specific sequence.

Pages

Subscribe to Latest News